SEC Form 3 · accession 0001140361-15-041873
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dori Christine Assaly
Officer — SVP, Legal & Corp. Secy.
Period of report
Nov 5, 2015
Accepted (ET)
Nov 16, 2015 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | holding | — | — | — | 500 | D |
Table II — derivative securities
No Table II lines on this filing.